Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 7-10 April 2025
Assessment templates and guidance
Human medicines European public assessment report (EPAR): Sialanar, glycopyrronium bromide, Date of authorisation: 15/09/2016, Revision: 12, Status: Authorised
Human medicines European public assessment report (EPAR): Orphacol, cholic acid, Date of authorisation: 12/09/2013, Revision: 15, Status: Authorised
Emergency Task Force (ETF)
Composition of the Emergency Task Force (ETF) for preparedness
Superseded - Composition of the Emergency Task Force (ETF) for preparedness
Rules of procedure of the Emergency Task Force (ETF)
Superseded - Rules of procedure of the Emergency Task Force (ETF)
CHMP-CAT - D80-210 Overview to final EPAR - Rev 04.25 (Revamp)